{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":29,"description":"The standard 2D Laparoscopy System to be used at time of the total laparoscopic hysterectomy\n\n2D Laparoscopy: The standard 2D Laparoscopy System to be used at time of the total laparoscopic hysterectomy.","id":"EG000","otherNumAffected":3,"otherNumAtRisk":29,"seriousNumAffected":0,"seriousNumAtRisk":29,"title":"2D Laparoscopy"},{"deathsNumAffected":0,"deathsNumAtRisk":28,"description":"The Storz 3D Laparoscopy System is the intervention we are studying at the time of the total laparoscopic hysterectomy.\n\nStorz 3D Laparoscopy System: The Storz 3D Laparoscopy System is a new device that allows for laparoscopic surgeons to utilize 3D imaging during surgery with a fraction of the cost of the da Vinci Surgical System, a three-dimensional visual system.","id":"EG001","otherNumAffected":4,"otherNumAtRisk":28,"seriousNumAffected":0,"seriousNumAtRisk":28,"title":"3D Laparoscopy"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subject presented to ER 5 days after discharge concerned about blood clot in hand where IV had been. Seen and prescribed warm compresses and discharged.","organSystem":"Skin and subcutaneous tissue disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":29,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":28,"numEvents":1}],"term":"ER visit"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subject presented to ER 18 days after surgery with abdominal pain. Rxed with dilaudid; required re-operation for cuff dehiscence.","organSystem":"Surgical and medical procedures","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":29,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":28,"numEvents":1}],"term":"Reoperation for vaginal cuff dehiscence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subject experienced some postoperative red/itching around incision sites - near smaller incisions like a rash; advised oral antihistamines and topical hydrocortisone for presumed dermabond reaction. Improved with treatment.","organSystem":"Skin and subcutaneous tissue disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":29,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":28,"numEvents":1}],"term":"Iritation around abdominal surgical incision site"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subject was treated with antibiotics for postoperative incision cellulitis.","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":29,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":28,"numEvents":1}],"term":"Incision cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subjected was treated with diflucan for postoperative yeast infection.","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":29,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":28,"numEvents":0}],"term":"Yeast infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Intraoperative cystotomy (bladder injury), repaired laparoscopically. Normal recovery.","organSystem":"Injury, poisoning and procedural complications","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":29,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":28,"numEvents":0}],"term":"Intraoperative complication"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Subject had postoperative urinary retention with transient Foley catheter needed but returned to normal by post-operative follow up.","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":29,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":28,"numEvents":0}],"term":"Urinary retention"}],"timeFrame":"Adverse event data was collected from the day of surgery to 8 weeks following the operation."}